S
ST Pharm Co Ltd
KOSDAQ:237690
ST Pharm Co Ltd
KOSDAQ:237690
Price:
142 500
KRW
-5.5%
Market Closed
Market Cap:
₩3T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
KR |
|
SCS Group PLC
LSE:SCS
|
UK |
Relative Value
The Relative Value of one ST Pharm Co Ltd stock under the Base Case scenario is 100 784.73 KRW. Compared to the current market price of 142 500 KRW, ST Pharm Co Ltd is Overvalued by 29%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
100 784.73
KRW
Overvaluation 29%
S
Multiples Across Competitors
Competitors Multiples
ST Pharm Co Ltd Competitors
ST Pharm Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
2.9T KRW | 9 | 77.8 | 36 | 55.7 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
961.5B USD | 336.6 | 3 986.1 | 1 142.2 | 2 199.5 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
179.9B USD | 4.1 | 27.5 | 19.1 | 25.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
134.3B USD | 5.5 | 37.2 | 19 | 27.6 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
32.1B CHF | 5.1 | 34.8 | 26 | 26 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
251.1B CNY | 5.7 | 16.7 | 16.7 | 16.7 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.7B USD | 4.6 | 25 | 18.4 | 21.8 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.6B USD | 9.3 | 46 | 29.7 | 37.4 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.3B USD | 1.8 | 21 | 11.7 | 17.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.2B USD | 6.4 | 29.7 | 22 | 24.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
